MedPath

FROVA

FROVA (frovatriptan succinate) Tablets

Approved
Approval ID

8ce8bf0a-8b21-41a5-bbea-71302312c2c5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 18, 2010

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FROVATRIPTAN SUCCINATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-396
Application NumberNDA021006
Product Classification
M
Marketing Category
C73594
G
Generic Name
FROVATRIPTAN SUCCINATE
Product Specifications
Route of AdministrationORAL
Effective DateJune 18, 2010
FDA Product Classification

INGREDIENTS (10)

FROVATRIPTAN SUCCINATEActive
Quantity: 2.5 mg in 1 1
Code: D28J6W18HY
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
HYPROMELLOSEInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL 3000Inactive
Code: SA1B764746
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIACETINInactive
Code: XHX3C3X673
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FROVA - FDA Drug Approval Details